Launch One Acquisition Corp. (LPAA)

NGM – Real Time Price. Currency in USD

10.77

-0.02 (-0.16%)

At close: May 12, 2026, 4:00 PM EDT

13.01.2026

Minovia Therapeutics Announces Two New U.S. Patents Granted, Strengthening Its Mitochondrial Augmentation Therapy Platform

New U.S. intellectual property protections expand use of Minovia's leading technology in mitochondrial-based therapies for primary mitochondrial and severe renal diseases New U.S. intellectual property protections expand use of Minovia's leading technology in mitochondrial-based therapies for primary mitochondrial and severe renal diseases

Videos

No Data

There is no data to display

Press releases

13.01.2026

Launch One Acquisition Corp. (LPAA)

Get all premium features to the best stock analysis tool

Finranks

Company

Contact us

Follow us

Launch One Acquisition Corp. (LPAA)

Minovia Therapeutics Announces Two New U.S. Patents Granted, Strengthening Its Mitochondrial Augmentation Therapy Platform

Videos

No Data

Press releases

Minovia Therapeutics Announces Two New U.S. Patents Granted, Strengthening Its Mitochondrial Augmentation Therapy Platform

Minovia Therapeutics Announces Two New U.S. Patents Granted, Strengthening Its Mitochondrial Augmentation Therapy Platform

Videos

No Data

Press releases

Minovia Therapeutics Announces Two New U.S. Patents Granted, Strengthening Its Mitochondrial Augmentation Therapy Platform

Search stocks

Launch One Acquisition Corp. (LPAA)

Get all premium features to the best stock analysis tool

Finranks

Company

Contact us

Follow us

Launch One Acquisition Corp. (LPAA)

Minovia Therapeutics Announces Two New U.S. Patents Granted, Strengthening Its Mitochondrial Augmentation Therapy Platform

Videos

No Data

Press releases

Minovia Therapeutics Announces Two New U.S. Patents Granted, Strengthening Its Mitochondrial Augmentation Therapy Platform

Minovia Therapeutics Announces Two New U.S. Patents Granted, Strengthening Its Mitochondrial Augmentation Therapy Platform

Videos

No Data

Press releases

Minovia Therapeutics Announces Two New U.S. Patents Granted, Strengthening Its Mitochondrial Augmentation Therapy Platform